[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-vertex-pharmaceuticals-stock-jumps-7-following-oppenheimer-upgrade-heres-where-the-stock-could-go-in-2026-FR":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":265,"suggestedPosts":339},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},92968,"L'action Vertex Pharmaceuticals bondit de 7 % suite à la révision à la hausse d'Oppenheimer : voici où l'action pourrait aller en 2026","2026-02-17T20:45:00","2026-02-20T05:24:50","\u003Cp>Vertex Pharmaceuticals a atteint un sommet de 5 semaines après que les analystes d'Oppenheimer ont relevé le titre, citant le potentiel massif de son pipeline de maladies rénales.\u003C\u002Fp>\n","\n\u003Ch3 class=\"wp-block-heading\" id=\"h-k-ey-stats-for-vertex-pharmaceuticals-stock\">\u003Cstrong>Statistiques clés\u003C\u002Fstrong> pour l'\u003Cstrong> action Vertex Pharmaceuticals\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Evolution récente :\u003C\u002Fstrong> +6,5%.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Prix actuel :\u003C\u002Fstrong> ~491\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Objectif du modèle d'évaluation :\u003C\u002Fstrong> 849\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Maintenant en ligne : Découvrez l'ampleur de la hausse de vos actions préférées en utilisant le nouveau modèle d'évaluation de TIKR (c'est gratuit).\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">>>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened\">Qu'est-ce qui s'est passé ?\u003C\u002Fh2>\n\n\n\n\u003Cp>\u003Cstrong>Vertex Pharmaceuticals (\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=36235&tid=2662297&?ref=tikrblog\">\u003Cstrong>VRTX\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong> ont atteint un sommet de 5 semaines vendredi après un important vote de confiance de la part de Wall Street.\u003C\u002Fp>\n\n\n\n\u003Cp>Le catalyseur a été une mise à niveau importante de la part d'Oppenheimer, qui a relevé sa note à \"Surperformer\" et fixé un objectif de prix de 540 $, ce qui représente une hausse significative par rapport aux niveaux actuels.\u003C\u002Fp>\n\n\n\n\u003Cp>Selon\u003Ca href=\"https:\u002F\u002Fwww.nasdaq.com\u002Farticles\u002Foppenheimer-upgrades-vertex-pharmaceuticals-vrtx\">les rapports\u003C\u002Fa>, la hausse a été motivée par l'enthousiasme croissant pour le pipeline émergent de Vertex dans le domaine des maladies rénales, en particulier le médicament povetacicept. \u003C\u002Fp>\n\n\n\n\u003Cp>Les investisseurs se rendent compte que Vertex n'est plus seulement une \"société spécialisée dans la mucoviscidose\".\u003C\u002Fp>\n\n\n\n\u003Cp>Ce sentiment a été partagé par l'ensemble du marché,\u003Ca href=\"https:\u002F\u002Ffinviz.com\u002Fnews\u002F310454\u002Fvertex-pharma-vrtx-renal-pipeline-seen-as-major-growth-driver-by-barclays\"> Barclays ayant relevé son objectif à 606 dollars\u003C\u002Fa> et UBS ayant porté son opinion à 545 dollars.\u003C\u002Fp>\n\n\n\n\u003Cp>Les analystes estiment que le marché sous-estime le potentiel \"multimilliardaire\" de la diversification dans les maladies rénales, le traitement de la douleur et l'édition de gènes.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"2560\" height=\"2102\" data-public-id=\"images\u002FVRTX_valuation_model_929912ee95\u002FVRTX_valuation_model_929912ee95.png\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2560,h_2102,c_scale\u002Ff_webp,q_auto\u002Fv1771307917\u002Fimages\u002FVRTX_valuation_model_929912ee95\u002FVRTX_valuation_model_929912ee95.png?_i=AA\" alt=\"\" class=\"wp-post-92968 wp-image-92991\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1771307917\" data-seo=\"1\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Objectif de cours de l'action Vertex Pharmaceuticals\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">(TIKR\u003C\u002Fa>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Voir les prévisions de croissance et les objectifs de prix des analystes pour l'action Vertex Pharmaceuticals (C'est gratuit !) >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-is-vertex-pharmaceuticals-undervalued-today\">\u003Cstrong>Vertex Pharmaceuticals est-elle sous-évaluée aujourd'hui ?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Le modèle TIKR suggère que l'action est significativement sous-évaluée, prévoyant une trajectoire vers $849 d'ici 2030, bien plus élevée que le prix actuel de ~$491.\u003C\u002Fp>\n\n\n\n\u003Cp>Lors de la conférence téléphonique sur les résultats, la PDG Reshma Kewalramani a justifié cette évaluation plus élevée en présentant le pipeline rénal comme un nouveau moteur de croissance massif.\u003C\u002Fp>\n\n\n\n\u003Cp>Elle a explicitement déclaré : \" Nous passons maintenant à notre pipeline rénal, qui est en train d'émerger comme notre quatrième vertical, avec la FK, l'hème et la douleur, en tant que moteur clé de la prochaine décennie de croissance de Vertex \".\u003C\u002Fp>\n\n\n\n\u003Cp>Le directeur commercial, Duncan McKechnie, a confirmé ce point en affirmant que la franchise rénale pourrait à terme égaler l'activité principale de l'entreprise : \"Nous prévoyons que la franchise rénale finira par rivaliser avec l'ampleur de notre activité dans le domaine de la fibrose kystique.\"\u003C\u002Fp>\n\n\n\n\u003Cp>Si Vertex peut effectivement doubler son marché potentiel, le multiple d'évaluation actuel est trop faible.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Lire la transcription complète de Vertex sur TIKR pour voir la feuille de route 2026 >>>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>Analyse approfondie de l'évaluation\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp>Le \u003Cstrong>modèle d'évaluation avancé de TIKR\u003C\u002Fstrong> brosse un tableau haussier qui va bien au-delà des récentes mises à jour des analystes.\u003C\u002Fp>\n\n\n\n\u003Cp>Le modèle prévoit une croissance composée constante à mesure que le pipeline arrive à maturité.\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Prix cible :\u003C\u002Fstrong> 849\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Prix actuel :\u003C\u002Fstrong> ~491\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Rendement annualisé :\u003C\u002Fstrong> 11.9%\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Cstrong>La prime \"pipeline dans un produit\" :\u003C\u002Fstrong> Le modèle attribue une valeur à l'optionnalité du pipeline. La direction a fait remarquer que le povetacicept n'est pas destiné à une seule maladie ; il s'agit d'un \"pipeline dans un produit\" qui peut traiter la néphropathie IgA, la néphropathie membraneuse et, potentiellement, la myasthénie grave.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>La diversification permet de réduire les risques liés aux actions :\u003C\u002Fstrong> Historiquement, Vertex s'est négocié avec une décote en raison de sa dépendance à l'égard de la mucoviscidose. À mesure que les revenus de CASGEVY (édition de gènes) et de JOURNAVX (douleur) augmentent, les prescriptions de JOURNAVX devant \"tripler\" en 2026, cette décote devrait s'évaporer, entraînant l'action vers l'objectif de 849 dollars du modèle.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>Conclusion\u003C\u002Fstrong>: Un moment de rupture. Avec un rendement annualisé de 11,9 % et un pipeline qui pourrait doubler les revenus de l'entreprise, Vertex Pharmaceuticals offre un rare mélange de stabilité et d'énorme potentiel de croissance. Le relèvement d'Oppenheimer à 540 $ pourrait bien être la première étape vers 849 $.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Découvrez les actions que les investisseurs milliardaires achètent afin que vous puissiez suivre l'argent intelligent avec TIKR.\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-how-much-upside-does-vertex-pharmaceuticals-stock-have-from-here\">Quelle est l'ampleur de la hausse de l'action Vertex Pharmaceuticals à partir de maintenant ?\u003C\u002Fh2>\n\n\n\n\u003Cp>Grâce au \u003Cstrong>nouveau modèle d'évaluation de\u003C\u002Fstrong> TIKR, vous pouvez estimer le prix potentiel d'une action en moins d'une minute.\u003C\u002Fp>\n\n\n\n\u003Cp>Tout ce qu'il faut, ce sont trois données simples :\u003C\u002Fp>\n\n\n\n\u003Col class=\"wp-block-list\">\n\u003Cli>\u003Cem>Croissance des revenus\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Marges d'exploitation\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Multiplicateur de prix de sortie\u003C\u002Fem>\u003C\u002Fli>\n\u003C\u002Fol>\n\n\n\n\u003Cp>Si vous n'êtes pas sûr de ce qu'il faut saisir, TIKR remplit automatiquement chaque entrée en utilisant les estimations consensuelles des analystes, ce qui vous donne un point de départ rapide et fiable.\u003C\u002Fp>\n\n\n\n\u003Cp>TIKR calcule ensuite le prix potentiel de l'action et le rendement total dans le cadre de \u003Cstrong>scénarios\u003C\u002Fstrong> \u003Cstrong>haussier, baissier et de base,\u003C\u002Fstrong> ce qui vous permet de voir rapidement si une action est \u003Cstrong>sous-évaluée ou surévaluée\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Découvrez la valeur réelle d'une action en moins de 60 secondes (gratuit avec TIKR) >>>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-looking-for-new-opportunities\">À la recherche de nouvelles opportunités ?\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Voyez quelles actions\u003Cstrong> \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">les investisseurs milliardaires achètent\u003C\u002Fa> \u003C\u002Fstrong>afin que vous puissiez suivre l'argent intelligent.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Analysez les actions en seulement 5 minutes\u003C\u002Fa>\u003C\u002Fstrong> grâce à la plateforme tout-en-un et facile à utiliser de TIKR.\u003C\u002Fli>\n\n\n\n\u003Cli>Plus vous renversez de pierres... plus vous découvrirez d'opportunités. \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Recherchez plus de 100 000 actions mondiales, les titres des principaux investisseurs mondiaux, et plus encore avec TIKR.\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Avis de non-responsabilité :\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>\u003Cem>Veuillez noter que les articles de TIKR ne sont pas destinés à servir de conseils financiers ou d'investissement de la part de TIKR ou de notre équipe de contenu, et qu'ils ne constituent pas non plus des recommandations d'achat ou de vente d'actions. Nous créons notre contenu en nous basant sur les données d'investissement de TIKR Terminal et sur les estimations des analystes. Notre analyse peut ne pas inclure des nouvelles récentes de l'entreprise ou des mises à jour importantes. TIKR n'a aucune position dans les actions mentionnées. Nous vous remercions de votre lecture et vous souhaitons de bons investissements !\u003C\u002Fem>\u003C\u002Fp>\n",760,"fr","\u002Fblog\u002Fvertex-pharmaceuticals-stock-jumps-7-following-oppenheimer-upgrade-heres-where-the-stock-could-go-in-2026","vertex-pharmaceuticals-stock-jumps-7-following-oppenheimer-upgrade-heres-where-the-stock-could-go-in-2026","images\u002F2-7_92970b13a4\u002F2-7_92970b13a4","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771306128\u002Fimages\u002F2-7_92970b13a4\u002F2-7_92970b13a4.png?_i=AA",{"altText":237,"imageCredit":238},"Vertex Pharmaceuticals Stock Jumps 7% Following Oppenheimer Upgrade: Here’s Where the Stock Could Go in 2026","@pixelshot via Canva",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Wiltone Asuncion","wiltonetikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"Thomas Richmond","thomastikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Vertex Pharmaceuticals hit a 5-week high after Oppenheimer analysts upgraded the stock, citing the massive potential of its kidney disease pipeline.",{"title":237,"description":258,"twitterTitle":237,"twitterDescription":258,"author":240,"articlePublisher":260,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":261,"twitterData1":262,"ogTitle":237,"ogDescription":258,"ogUrl":232,"ogImage":235,"ogImageWidth":263,"ogImageHeight":264,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"TIKR.com","Temps de lecture estimé","6 minutes",1200,630,[266,281,295,309,324],{"id":255,"title":267,"date":268,"excerpt":269,"wordCount":270,"uri":271,"slug":272,"cloudinaryAssetId":273,"featuredImageOriginalUrl":274,"featuredImageMetadata":275,"author":276,"categories":278,"relatedPosts":280},"L'action Newmont est en hausse de 7 % dans le cadre d'un rallye historique de l'or. Voici où l'action pourrait se diriger en 2026","2026-02-17 20:15:00","Newmont Corporation a bondi de 7 %, les prix de l'or ayant battu des records, dépassant les 5 000 dollars l'once. ",742,"\u002Fblog\u002Fnewmont-stock-is-up-7-amid-historic-gold-rally-heres-where-the-stock-could-be-headed-in-2026","newmont-stock-is-up-7-amid-historic-gold-rally-heres-where-the-stock-could-be-headed-in-2026","images\u002F4-7_92972c9703\u002F4-7_92972c9703","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771306161\u002Fimages\u002F4-7_92972c9703\u002F4-7_92972c9703.png?_i=AA",{"altText":267},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":277},[],[279],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":282,"date":268,"excerpt":283,"wordCount":284,"uri":285,"slug":286,"cloudinaryAssetId":287,"featuredImageOriginalUrl":288,"featuredImageMetadata":289,"author":290,"categories":292,"relatedPosts":294},"L'action d'Airbnb s'inscrit dans le cadre d'un boom des voyages : pourquoi la demande estivale record justifie un objectif de 265 $.","Les actions d'Airbnb ont grimpé après que Deutsche Bank a émis une note \"Acheter\", citant une ré-accélération de la demande de voyages. ",768,"\u002Fblog\u002Fairbnb-stock-is-pricing-in-a-major-travel-boom-why-record-summer-demand-supports-a-265-target","airbnb-stock-is-pricing-in-a-major-travel-boom-why-record-summer-demand-supports-a-265-target","images\u002F3-7_92971a891a\u002F3-7_92971a891a","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771306145\u002Fimages\u002F3-7_92971a891a\u002F3-7_92971a891a.png?_i=AA",{"altText":282},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":291},[],[293],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":296,"date":297,"excerpt":298,"wordCount":230,"uri":299,"slug":300,"cloudinaryAssetId":301,"featuredImageOriginalUrl":302,"featuredImageMetadata":303,"author":304,"categories":306,"relatedPosts":308},"L'action Flutter Entertainment recule de 12% suite à l'avertissement de son rival : Voici où l'action pourrait se diriger en 2026","2026-02-17 20:00:00","Les actions de Flutter Entertainment (FanDuel) ont plongé en même temps que celles de DraftKings, qui a publié des perspectives décevantes pour 2026. ","\u002Fblog\u002Fflutter-entertainment-stock-pulls-back-12-on-rivals-warning-heres-where-the-stock-could-be-headed-in-2026","flutter-entertainment-stock-pulls-back-12-on-rivals-warning-heres-where-the-stock-could-be-headed-in-2026","images\u002F12-6\u002F12-6","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771306811\u002Fimages\u002F12-6\u002F12-6.png?_i=AA",{"altText":296},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":305},[],[307],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":310,"date":311,"excerpt":312,"wordCount":313,"uri":314,"slug":315,"cloudinaryAssetId":316,"featuredImageOriginalUrl":317,"featuredImageMetadata":318,"author":319,"categories":321,"relatedPosts":323},"L'action NRG Energy bondit de 7 % après une hausse massive des prévisions. Voici l'ampleur de la hausse de l'action en 2026","2026-02-17 19:45:00","Les actions de NRG Energy ont bondi de 7 % après que la direction a augmenté ses prévisions pour 2026 de près de 35 %, citant la clôture de l'acquisition de LS Power. ",778,"\u002Fblog\u002Fnrg-energy-stock-jumps-7-after-massive-guidance-hike-heres-how-much-upside-the-stock-could-have-in-2026","nrg-energy-stock-jumps-7-after-massive-guidance-hike-heres-how-much-upside-the-stock-could-have-in-2026","images\u002F5-7_92974a34a8\u002F5-7_92974a34a8","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771306179\u002Fimages\u002F5-7_92974a34a8\u002F5-7_92974a34a8.png?_i=AA",{"altText":310},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":320},[],[322],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":325,"date":326,"excerpt":327,"wordCount":328,"uri":329,"slug":330,"cloudinaryAssetId":331,"featuredImageOriginalUrl":332,"featuredImageMetadata":333,"author":334,"categories":336,"relatedPosts":338},"L'action de Trupanion est en baisse de 13 % à la suite des résultats du quatrième trimestre : Les analystes prévoient-ils un rebond à 70 $ en 2026 ?","2026-02-17 19:30:00","L'action de Trupanion s'est effondrée après que l'assureur pour animaux de compagnie a annoncé des résultats insuffisants en raison d'une hausse des coûts d'acquisition des clients. ",809,"\u002Fblog\u002Ftrupanion-stock-is-down-13-following-q4-results-do-analysts-see-a-rebound-to-70-in-2026","trupanion-stock-is-down-13-following-q4-results-do-analysts-see-a-rebound-to-70-in-2026","images\u002F11-7\u002F11-7","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771306277\u002Fimages\u002F11-7\u002F11-7.png?_i=AA",{"altText":325},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":335},[],[337],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[340,360,375,390,405,419,439,454,469,484],{"id":255,"title":341,"date":342,"excerpt":343,"wordCount":344,"uri":345,"slug":346,"cloudinaryAssetId":347,"featuredImageOriginalUrl":348,"featuredImageMetadata":349,"author":350,"categories":354,"relatedPosts":359},"L'action Vita Coco chute de 11 % après la publication des résultats : Voici ce que les investisseurs digèrent","2026-02-19 23:00:00","Voici pourquoi l'action Vita Coco a reculé malgré des résultats trimestriels solides, et comment les objectifs de prix des analystes influencent les perspectives de l'action à partir d'aujourd'hui.",624,"\u002Fblog\u002Fthe-vita-coco-stock-drops-11-after-earnings-beat-heres-what-investors-are-digesting","the-vita-coco-stock-drops-11-after-earnings-beat-heres-what-investors-are-digesting","images\u002FCOCO-stock\u002FCOCO-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771498864\u002Fimages\u002FCOCO-stock\u002FCOCO-stock.png?_i=AA",{"altText":341},{"name":351,"slug":352,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":353},"Rexielyn Diaz","rexietikr",[],[355],{"name":356,"slug":357,"uri":358,"description":243,"postsCount":255},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",[],{"id":255,"title":361,"date":362,"excerpt":363,"wordCount":364,"uri":365,"slug":366,"cloudinaryAssetId":367,"featuredImageOriginalUrl":368,"featuredImageMetadata":369,"author":370,"categories":372,"relatedPosts":374},"L'action de Glaukos bondit de 13 % après les résultats positifs du quatrième trimestre : Voici ce que signifient ses prévisions pour 2026","2026-02-19 22:30:00","Voici pourquoi l'action Glaukos s'envole après avoir enregistré une croissance de 36 % de son chiffre d'affaires au quatrième trimestre et revu à la hausse ses prévisions de ventes pour 2026.",658,"\u002Fblog\u002Fglaukos-stock-jumps-13-after-q4-beat-heres-what-its-2026-guidance-signals","glaukos-stock-jumps-13-after-q4-beat-heres-what-its-2026-guidance-signals","images\u002FGKOS-stock\u002FGKOS-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771498231\u002Fimages\u002FGKOS-stock\u002FGKOS-stock.png?_i=AA",{"altText":361},{"name":351,"slug":352,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":371},[],[373],{"name":356,"slug":357,"uri":358,"description":243,"postsCount":255},[],{"id":255,"title":376,"date":377,"excerpt":378,"wordCount":379,"uri":380,"slug":381,"cloudinaryAssetId":382,"featuredImageOriginalUrl":383,"featuredImageMetadata":384,"author":385,"categories":387,"relatedPosts":389},"L'action de Global Payments a bondi de 16 % après la publication de ses résultats : Voici ce que signifie un rachat de 2,5 milliards de dollars","2026-02-19 22:00:00","Voici pourquoi l'action de Global Payments (GPN) a bondi de 16 % après sa victoire au quatrième trimestre et l'annonce d'un rachat de 2,5 milliards de dollars.",726,"\u002Fblog\u002Fglobal-payments-stock-surged-16-after-earnings-beat-heres-what-a-2-5-billion-buyback-signals","global-payments-stock-surged-16-after-earnings-beat-heres-what-a-2-5-billion-buyback-signals","images\u002FGPN-stock\u002FGPN-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771497243\u002Fimages\u002FGPN-stock\u002FGPN-stock.png?_i=AA",{"altText":376},{"name":351,"slug":352,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":386},[],[388],{"name":356,"slug":357,"uri":358,"description":243,"postsCount":255},[],{"id":255,"title":391,"date":392,"excerpt":393,"wordCount":394,"uri":395,"slug":396,"cloudinaryAssetId":397,"featuredImageOriginalUrl":398,"featuredImageMetadata":399,"author":400,"categories":402,"relatedPosts":404},"L'action d'ImmunityBio s'envole de 42% après les nouvelles autorisations d'Anktiva. Voici ce qui motive le rallye","2026-02-19 21:30:00","Voici pourquoi l'action d'ImmunityBio a bondi de 42 %, alors que les nouvelles autorisations d'Anktiva et la croissance rapide du chiffre d'affaires ont alimenté une forte réévaluation de cette biotech à haut risque.",694,"\u002Fblog\u002Fimmunitybio-stock-soars-42-after-new-anktiva-approvals-heres-whats-driving-the-rally","immunitybio-stock-soars-42-after-new-anktiva-approvals-heres-whats-driving-the-rally","images\u002FIBRX-stock-2\u002FIBRX-stock-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771479866\u002Fimages\u002FIBRX-stock-2\u002FIBRX-stock-2.png?_i=AA",{"altText":391},{"name":351,"slug":352,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":401},[],[403],{"name":356,"slug":357,"uri":358,"description":243,"postsCount":255},[],{"id":255,"title":406,"date":407,"excerpt":408,"wordCount":364,"uri":409,"slug":410,"cloudinaryAssetId":411,"featuredImageOriginalUrl":412,"featuredImageMetadata":413,"author":414,"categories":416,"relatedPosts":418},"L'action d'Axcelis Technologies chute de 17 % après la publication des résultats. Voici ce que des prévisions plus souples pour 2026 signifient pour la demande d'équipement en puces électroniques","2026-02-19 21:00:00","Voici pourquoi l'action d'Axcelis a chuté de 17% après que les résultats positifs du quatrième trimestre aient été éclipsés par des prévisions médiocres pour 2026 et par l'incertitude liée à la fusion.","\u002Fblog\u002Faxcelis-technologies-stock-drops-17-after-earnings-heres-what-soft-2026-guidance-signals-for-chip%e2%80%91equipment-demand","axcelis-technologies-stock-drops-17-after-earnings-heres-what-soft-2026-guidance-signals-for-chip%e2%80%91equipment-demand","images\u002FACLS-stock\u002FACLS-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771478599\u002Fimages\u002FACLS-stock\u002FACLS-stock.png?_i=AA",{"altText":406},{"name":351,"slug":352,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":415},[],[417],{"name":356,"slug":357,"uri":358,"description":243,"postsCount":255},[],{"id":255,"title":420,"date":421,"excerpt":422,"wordCount":423,"uri":424,"slug":425,"cloudinaryAssetId":426,"featuredImageOriginalUrl":427,"featuredImageMetadata":428,"author":429,"categories":433,"relatedPosts":438},"Merck bat les bénéfices du T4 mais manque ses prévisions pour 2026. Voici ce que les investisseurs doivent savoir","2026-02-19 19:23:00","Wall Street a passé des mois à traiter Merck comme une entreprise à médicament unique confrontée à la falaise de KEYTRUDA. Trois approbations de la FDA, un accord avec la Mayo Clinic AI et un objectif de 179 dollars pour le modèle montrent que cette histoire est dangereusement dépassée.\n",774,"\u002Fblog\u002Fmerck-beat-q4-earnings-but-missed-2026-guidance-heres-what-investors-need-to-know","merck-beat-q4-earnings-but-missed-2026-guidance-heres-what-investors-need-to-know","images\u002FFEATURED-IMAGE-MAKER-258\u002FFEATURED-IMAGE-MAKER-258","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771515753\u002Fimages\u002FFEATURED-IMAGE-MAKER-258\u002FFEATURED-IMAGE-MAKER-258.png?_i=AA",{"altText":420},{"name":430,"slug":431,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":432},"Gian Estrada","giantikr",[],[434],{"name":435,"slug":436,"uri":437,"description":243,"postsCount":255},"Évaluation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":255,"title":440,"date":441,"excerpt":442,"wordCount":443,"uri":444,"slug":445,"cloudinaryAssetId":446,"featuredImageOriginalUrl":447,"featuredImageMetadata":448,"author":449,"categories":451,"relatedPosts":453},"L'action McKesson a progressé de 58 % au cours de la dernière année : Voici pourquoi les analystes signalent une surévaluation potentielle","2026-02-19 16:00:00","Le 4 février, l'action McKesson a relevé ses prévisions de BPA ajusté pour l'exercice 2026 à 38,80 $ - 39,20 $ après que le bénéfice d'exploitation du segment oncologie a bondi de 57 %, mais trois initiés de haut niveau ont cédé des actions dans les 10 jours suivant la publication des résultats, créant ainsi une tension que le rendement annualisé de 5,7 % pourrait ne pas résoudre.",2137,"\u002Fblog\u002Fmckesson-stock-has-rallied-58-over-the-past-year-heres-why-analysts-flag-a-potential-overvaluation","mckesson-stock-has-rallied-58-over-the-past-year-heres-why-analysts-flag-a-potential-overvaluation","images\u002FFEATURED-IMAGE-MAKER-256\u002FFEATURED-IMAGE-MAKER-256","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771506399\u002Fimages\u002FFEATURED-IMAGE-MAKER-256\u002FFEATURED-IMAGE-MAKER-256.png?_i=AA",{"altText":440},{"name":430,"slug":431,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":450},[],[452],{"name":435,"slug":436,"uri":437,"description":243,"postsCount":255},[],{"id":255,"title":455,"date":456,"excerpt":457,"wordCount":458,"uri":459,"slug":460,"cloudinaryAssetId":461,"featuredImageOriginalUrl":462,"featuredImageMetadata":463,"author":464,"categories":466,"relatedPosts":468},"L'action DaVita est en hausse de 35 % depuis février. Voici où les actions pourraient aller en 2026","2026-02-19 14:20:00","Un bond de 33 % des prévisions de BPA, un pari d'expansion de 200 millions de dollars et une étape de rentabilité attendue depuis longtemps. Voici pourquoi la hausse de 35 % de DaVita en février pourrait n'être qu'un début.",713,"\u002Fblog\u002Fdavita-stock-is-up-35-since-february-heres-where-shares-could-go-in-2026","davita-stock-is-up-35-since-february-heres-where-shares-could-go-in-2026","images\u002FFEATURED-IMAGE-MAKER-257\u002FFEATURED-IMAGE-MAKER-257","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771509556\u002Fimages\u002FFEATURED-IMAGE-MAKER-257\u002FFEATURED-IMAGE-MAKER-257.png?_i=AA",{"altText":455},{"name":430,"slug":431,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":465},[],[467],{"name":435,"slug":436,"uri":437,"description":243,"postsCount":255},[],{"id":255,"title":470,"date":471,"excerpt":472,"wordCount":473,"uri":474,"slug":475,"cloudinaryAssetId":476,"featuredImageOriginalUrl":477,"featuredImageMetadata":478,"author":479,"categories":481,"relatedPosts":483},"L'action IDEXX a progressé de 40 % au cours de l'année écoulée : Un nouveau PDG peut-il maintenir l'élan ?","2026-02-19 13:17:00","L'annonce de la succession du PDG d'IDEXX Laboratories en janvier, associée aux prévisions de février de la direction qui intègrent une baisse de 2 % des visites en clinique aux États-Unis, pourrait offrir une hausse totale de 59 % jusqu'en décembre 2030 si la nouvelle direction maintient la trajectoire des revenus récurrents de CAG Diagnostics qui a entraîné une appréciation de l'action de 64 % en 2025.",2079,"\u002Fblog\u002Fidexx-stock-has-rallied-40-over-the-past-year-can-a-new-ceo-keep-the-momentum-going","idexx-stock-has-rallied-40-over-the-past-year-can-a-new-ceo-keep-the-momentum-going","images\u002FFEATURED-IMAGE-MAKER-255\u002FFEATURED-IMAGE-MAKER-255","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771497436\u002Fimages\u002FFEATURED-IMAGE-MAKER-255\u002FFEATURED-IMAGE-MAKER-255.png?_i=AA",{"altText":470},{"name":430,"slug":431,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":480},[],[482],{"name":435,"slug":436,"uri":437,"description":243,"postsCount":255},[],{"id":255,"title":485,"date":486,"excerpt":487,"wordCount":488,"uri":489,"slug":490,"cloudinaryAssetId":491,"featuredImageOriginalUrl":492,"featuredImageMetadata":493,"author":494,"categories":496,"relatedPosts":498},"L'action IQVIA a déjà baissé de 25 % cette année : Voici ce que disent les analystes","2026-02-19 13:00:00","L'action IQVIA a chuté de 8 % le 5 février, après avoir annoncé un bénéfice par action ajusté pour 2026 de 12,55 à 12,85 dollars, inférieur au consensus de 12,95 dollars, même si le carnet de commandes de R&DS a atteint un record de 32,7 milliards de dollars, ce qui laisse une marge de 67 % par rapport à l'objectif intermédiaire que le ratio cours\u002Fbénéfice prévisionnel actuel de 13x ne permet peut-être pas encore d'évaluer.",2113,"\u002Fblog\u002Fiqvia-stock-dropped-8-on-weak-eps-guidance-heres-what-the-numbers-say-in-2026","iqvia-stock-dropped-8-on-weak-eps-guidance-heres-what-the-numbers-say-in-2026","images\u002FFEATURED-IMAGE-MAKER-254\u002FFEATURED-IMAGE-MAKER-254","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771471536\u002Fimages\u002FFEATURED-IMAGE-MAKER-254\u002FFEATURED-IMAGE-MAKER-254.png?_i=AA",{"altText":485},{"name":430,"slug":431,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":495},[],[497],{"name":435,"slug":436,"uri":437,"description":243,"postsCount":255},[]]